Pharmacokinetics and metabolism of nicotine.

Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue 2

Abstract

Nicotine (NIC), the major constituent of tobacco, is responsible for the compulsive use of tobacco. Advances in understanding of the pharmacokinetics and metabolism of NIC have been made rapidly over the past decade. The application of highly sensitive gas chromatography/mass spectrometry led to the identification and quantitation of new NIC metabolites as well as characterization of new pathways of NIC biotransformation. This review summarizes findings from human and animal studies concerning NIC kinetics and biotransformation as well as describes the factors that influence these processes. Recently, large individual, racial and species differences in the metabolism of NIC have been well documented. The differences in the metabolism of NIC may be a result of genetic, environmental, and developmental host influences. We review the scientific evidence from studies that supports a role for genetic mechanisms responsible for variability in the profile and the rate of the NIC metabolism. Actually, the majority of the genetic studies focus on the characterization of the CYP2A6 gene polymorphism, and on determining the relationship between the phenotype of NIC metabolism and the genotype of the CYP2A6 gene. There is good evidence that genetic polymorphisms associated with NIC metabolism are an important factor responsible for susceptibility to NIC dependence. It is anticipated that genetic findings can lead to the identification of individuals at a greater risk for tobacco addiction and will be used for more effective treatment and prevention strategies to reduce smoking.

Authors and Affiliations

Piotr Tutka, Jerzy Mosiewicz, Marian Wielosz

Keywords

Related Articles

Early lifetime zinc supplementation protects zinc-deficient diet-induced alterations.

Preclinical and clinical data indicate the involvement of zinc in the pathophysiology and therapy of depression. A relationship between zinc-deficiency and depression symptoms was recently proposed. The present study inv...

Effects of lipoic acid on spleen oxidative stress after LPS administration.

Background: Bacterial endotoxin (lipopolysaccharide - LPS) is a strong modulator of the immune system that plays a crucial role in the pathogenesis of endotoxic shock. The aim of the study was to investigate the effects...

Impact of the changes in P-glycoprotein activity on domperidone pharmacokinetics in rat plasma.

The effect of quinidine (QD) and grapefruit juice (GFJ) extract, P-glycoprotein inhibitors, on the domperidone (DOM) concentration in rat plasma was investigated. DOM, a dopamine D(2)-receptor antagonist is a substrate f...

Effects of agmatine on nicotine-evoked behavioral responses in rats.

Agmatine [2-(4-aminobutyl)guanidine], is a novel endogenous ligand at alpha(2)-adrenoceptors, imidazoline and N-methyl-D-asparate receptors, as well as a nitric oxide synthase inhibitor. The present study tested whether...

Download PDF file
  • EP ID EP91032
  • DOI -
  • Views 120
  • Downloads 0

How To Cite

Piotr Tutka, Jerzy Mosiewicz, Marian Wielosz (2005). Pharmacokinetics and metabolism of nicotine.. Pharmacological Reports, 57(2), 143-153. https://europub.co.uk/articles/-A-91032